Advertisement
Screener

Pediatrix Medical Group, Inc. (MD) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value

Pediatrix Medical Group, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value

Pediatrix Medical Group, Inc. (MD) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $12.86 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2025-02-20

  • Pediatrix Medical Group, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2024 was $12.86, a 43.12% decline from fiscal 2023.
  • Pediatrix Medical Group, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2023 was $22.61, a 7.56% decline from fiscal 2022.
  • Pediatrix Medical Group, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2022 was $24.46, a 13.26% decline from fiscal 2021.
  • Pediatrix Medical Group, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2021 was $28.20, a 10.98% decline from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month
2024-12-31$12.86
10-K · filed 2025-02-20
2023-12-31$22.61
10-K · filed 2024-02-20
2022-12-31$24.46
10-K · filed 2023-02-17
2021-12-31$28.20
10-K · filed 2022-02-17
2020-12-31$31.68
10-K · filed 2021-02-18
2019-12-31$48.37
10-K · filed 2020-02-20
2018-12-31$56.65
10-K · filed 2019-02-14
2017-12-31$64.82
10-K · filed 2018-02-14
2016-12-31$66.18
10-K · filed 2017-02-10
2015-12-31$55.77
10-K · filed 2016-02-11
2014-12-31$42.19
10-K · filed 2015-02-09
2013-12-31$35.37
10-K · filed 2014-02-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Encompass Health Corp (EHC)United States$12.039B16.15